针刺改善反复种植失败患者子宫内膜容受性
本研究回顾性分析609例反复种植失败(RIF)行冻胚移植患者,经倾向性评分匹配后针刺联合激素组与单纯激素组各166例。针刺组临床妊娠率36.5%、活产率28.0%等均显著高于对照组,子宫内膜厚度及雌孕激素水平更高,子宫血流阻力指数更低。年龄<35岁、BMI<24 kg/m2、AMH>2 ng/mL及优质或双胚胎移植者获益最明显。
要点
- 针刺联合激素治疗可提高RIF患者临床妊娠率至36.5%、活产率至28.0%。
- 针刺改善子宫内膜厚度及雌孕激素水平,降低子宫血流阻力。
- 年龄<35岁、BMI<24 kg/m2、AMH>2 ng/mL者针刺获益更显著。
核心结论
- 针刺可显著改善RIF患者子宫内膜容受性并提高活产率。
- 年轻、低BMI、高AMH及优质或双胚胎移植者从针刺辅助治疗中获益最大。
研究设计与样本
- 回顾性队列研究,纳入2019年1月至2022年6月行冻胚移植的609例RIF患者。
- 按是否接受针刺联合激素替代治疗(HRT/d-HRT)分为两组,采用倾向性评分匹配(PSM)后每组166例。
主要发现
- 针刺组临床妊娠率36.5%、活产率28.0%、持续妊娠率及生化妊娠率均显著高于对照组(P<0.05)。
- 针刺组子宫内膜厚度及雌二醇、孕酮水平显著更高,子宫阻力指数和搏动指数更低(P<0.05)。
- 活产预测因素包括年龄<35岁(HR=0.933,P=0.002)、BMI<24 kg/m2(HR=0.974,P=0.046)、AMH>2 ng/mL(HR=1.021,P=0.043)、优质胚胎移植(HR=1.670,P<0.05)及双胚胎移植(HR=1.181,P<0.05)。
临床怎么用
- 对RIF患者行冻胚移植前,可考虑联合针刺以改善子宫内膜容受性及妊娠结局。
- 针刺获益在年龄<35岁、BMI<24 kg/m2、AMH>2 ng/mL及优质或双胚胎移植患者中更明显。
局限性
- 本研究为回顾性队列研究,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluated the effectiveness of acupuncture for improving pregnancy outcomes, endometrial receptivity (ER), and embryo transfer success in patients with recurrent implantation failure (RIF). METHODS: A retrospective cohort study was conducted using the medical records of 609 RIF patients undergoing frozen embryo transfer between January 2019 and June 2022. Patients were divided into two groups: those receiving acupuncture combined with hormone replacement therapy (HRT) or delayed HRT (d-HRT) and those receiving only HRT/d-HRT. Propensity score matching (PSM) ensured comparability between the groups. Clinical outcomes, including live birth rate (LBR), clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and biochemical pregnancy rate (BPR), were analyzed. Endometrial thickness, hormonal levels and uterine blood flow were also assessed. RESULTS: After PSM, 166 patients were included in each group. The acupuncture group demonstrated significantly higher CPR (36.5%), LBR (28.0%), OPR and BPR compared to the control group (P < 0.05). Endometrial thickness, and estradiol and progesterone levels were also significantly higher, while uterine resistance and pulsatility indices were lower in the acupuncture group (P < 0.05). Predictors of live birth included patient age (< 35 years, hazard ratio [HR] = 0.933, P = 0.002), body mass index (BMI) (< 24 kg/m2, HR = 0.974, P = 0.046), anti-Müllerian hormone (AMH) level (> 2 ng/mL, HR = 1.021, P = 0.043), high-quality embryo transfers (HR = 1.670, P < 0.05), and transferring two embryos (HR = 1.181, P < 0.05). CONCLUSION: Acupuncture significantly enhanced ER and improved LBR in RIF patients. Younger patients with lower BMI, higher AMH level, and high-quality or dual embryo transfers benefited most from this complementary therapy. Please cite this article as: Li HZ, Wu YJ, Li XR, Deng B, Pang YX, Lin SY, Lu LM, Li YM. Enhancing pregnancy outcomes in recurrent implantation failure: The role of acupuncture in improving endometrial receptivity. J Integr Med. 2026; 24(3):394-402.
引用
- Li HZ, Wu YJ, Li XR, et al. Enhancing pregnancy outcomes in recurrent implantation failure: The role of acupuncture in improving endometrial receptivity. J Integr Med. 2026. PMID: 41833466. doi:10.1016/j.joim.2025.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。